Trial intelligence / Profile preview

THR-18 in Acute Ischemic Stroke

NCT01253512Phase 2Unknown

Sponsor
Thrombotech Ltd.
Start
Mar 2011
Primary completion
Dec 2011
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of THR-18 in acute ischemic stroke (AIS), sponsored by Thrombotech Ltd.. Status: unknown.

02

Drugs

THR-18
03

Conditions

acute ischemic stroke (AIS)

Beyond the preview

Go deeper on NCT01253512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01253512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call